Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(16 sites)
United States
Hoag Memorial Presbyterian, Newport Beach, California University of Iowa Hospitals and Clinics, Iowa City, Iowa Md Anderson Cancer Center, Houston, Texas Fred Hutchinson Cancer Research Center, Seattle, Washington Australia
Saint Vincents Hospital Sydney, Darlinghurst, New South Wales Calvary Mater Newcastle, Waratah, New South Wales Sunshine Coast University Private Hospital, Birtinya, Queensland Peter Maccallum Cancer Centre, Melbourne, Victoria Western Health Sunshine Hospital, St Albans, Victoria Linear Clinical Research, Nedlands, Western Australia China
Sun Yat Sen Memorial Hospital, Sun Yat Sen University (South), Guangzhou, Guangdong The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan The First Affiliated Hospital of Nanchang University Branch Donghu, Nanchang, Jiangxi Fudan University Shanghai Cancer Centerpudong, Shanghai, Shanghai Municipality Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin Municipality Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang